Predictors of left ventricular recovery in a cohort of peripartum cardiomyopathy patients recruited via the internet

Safirstein, Jordan; Ro, Angela S.; Grandhi, Sreeram; Wang, Lin; Fett, James D.; Staniloae, Cezar

doi:10.1016/j.ijcard.2010.08.065

Cited by 114 publications

(76 citation statements)

References 34 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…59 A retrospective Internet-recruited study in the United States showed that breastfeeding was associated with a better, rather than worse, maternal outcome. 60 In summary, the use of bromocriptine and voluntary cessation of lactation remain investigational and of uncertain benefit at this time. We hope that the results of an ongoing prospective, randomized, controlled trial of bromocriptine in 60 patients in Germany 61 will provide more information on the efficacy and safety of bromocriptine.…”

Section: Bromocriptine and Cessation Of Breastfeedingmentioning

confidence: 99%

Peripartum Cardiomyopathy

2016

View full text Add to dashboard Cite

Abstract-Peripartum cardiomyopathy is a potentially life-threatening pregnancy-associated disease that typically arises in the peripartum period and is marked by left ventricular dysfunction and heart failure. The disease is relatively uncommon, but its incidence is rising. Women often recover cardiac function, but long-lasting morbidity and mortality are not infrequent. Management of peripartum cardiomyopathy is largely limited to the same neurohormonal antagonists used in other forms of cardiomyopathy, and no proven disease-specific therapies exist yet. Research in the past decade has suggested that peripartum cardiomyopathy is caused by vascular dysfunction, triggered by late-gestational maternal hormones. Most recently, information has also indicated that many cases of peripartum cardiomyopathy have genetic underpinnings. We review here the known epidemiology, clinical presentation, and management of peripartum cardiomyopathy, as well as the current knowledge of the pathophysiology of the disease.

show abstract

Section: Bromocriptine and Cessation Of Breastfeedingmentioning

confidence: 99%

Peripartum Cardiomyopathy

2016

View full text Add to dashboard Cite

show abstract

“…When diagnosis is made with LVEF greater than 30 to 35% with appropriate treatment, the recovery rates are almost 100% [7,8]. 4% of patients will require cardiac transplantation and a overall mortality rate of approximately between 4 to10 percent at a mean follow-up of about two years [9][10][11].…”

Section: Discussionmentioning

confidence: 99%

Reproductive Medicine

Guillermo¹,

Tajudeen²

2014

J IVF Reprod Med Genet

View full text Add to dashboard Cite

“…Ретроспективное Интернет-исследование в США показало, что грудное вскарм-ливание ассоциируется с более благоприятным материнским прогнозом [54]. Таким образом, ис-пользование бромокриптина и целенаправленное прекращение лактации в настоящее время остаётся спорным.…”

Section: патогенетическая терапия перипартальной кардиомиопатииunclassified